欢迎来到天天文库
浏览记录
ID:32866445
大小:1.67 MB
页数:40页
时间:2019-02-16
《固本安肠汤治疗腹泻型肠易激综合征的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、陕西中医学院硕士学位论文固本安肠汤治疗腹泻型肠易激综合征的临床研究姓名:韩文冬申请学位级别:硕士专业:中医内科学指导教师:黄雅慧201204中文摘要目的:观察固本安肠汤治疗腹泻型肠易激综合征(IBS—D)肝郁脾虚兼肠失固摄型的临床疗效及其安全性。方法:选取符合临床纳入标准及排除标准的肝郁脾虚兼肠失固摄型腹泻型肠易激综合征患者96例,采用随机对照的原则,将96例患者随机分为治疗组48例、对照组48例。治疗组予口服固本安肠汤水煎剂,日一剂300ml,每次150ml,早饭前及晚饭后加热温服。对照组予口服马来酸曲美布汀片每次0.29,每日3次,饭前半小时口服;复合乳酸菌胶囊每次0.669,每日
2、3次,饭后半小时口服。两组均以4周为1个疗程,观察2个疗程,疗程结束后对所有的观察病例予以统计分析,进行疗效和安全性评定,并对显效及显效以上的病例进行约诊或随访以考察远期疗效。结果:(1)临床综合疗效比较:总有效率治疗组为93.3%,对照组为74.4%,有显著性差异(PO.05);治疗后两组患者中医证侯总积分较治疗前均有显著性差异(尸3、中医证侯。(3)两组治疗前后主要临床症状疗效比较:治疗组对改善腹泻、腹痛、粘液便、肠鸣、抑郁烦躁、倦怠乏力等症疗效优于对照组(P4、;临床研究SoIidintrinsicaIYsafeintestinaIDecoctioninthetreatmentofdiarrheatypeofiritabIeboweIsyndromeAbstractObjective:ToobservetheSolidintrinsicallysafeintestinalDecoctioninthetreatmentofdiarrheatypeofirritablebowelsyndrome(IBS—D)liverdepressionandspleendeficiencyandintestinallossofsolidoxygentypeth5、eclinicalefficacyandsafety.Methods:Selectionconsistentwithclinicalinclusioncriteriaandexclusioncriteriaofliverdepressionandspleendeficiencyandintestinallossofsolidoxygentypeofdiarrheatypeofirritablebowelsyndromein96cases,usingarandomizedcontrolledprinciple,96patientswererandomlydividedintothetre6、atmentgroup48examples,thecontrolgroupof48cases.Thetreatmentgroupreceivedoralsolidintrinsicallysafeintestinalsoupdecoction,dailydoses,150mleachtime,beforebreakfastanddinnerafterheatingclothes;thecontrolgroupreceivedoralmaleicacidQumeiclothineachlOOmg,Lactobacilluscomplexcapsuleseachtime0.669,are37、timesaday,halfanhourbeforeoral.Thetwogroupswere4weeksaslcoursesoftreatment,observationoftreatment2,aftertheendoftreatmentforallcaseswereobservedtobestatisticalanalysiS,forefficacyandsafetyevaluationofeffectandeffectandmoreca
3、中医证侯。(3)两组治疗前后主要临床症状疗效比较:治疗组对改善腹泻、腹痛、粘液便、肠鸣、抑郁烦躁、倦怠乏力等症疗效优于对照组(P4、;临床研究SoIidintrinsicaIYsafeintestinaIDecoctioninthetreatmentofdiarrheatypeofiritabIeboweIsyndromeAbstractObjective:ToobservetheSolidintrinsicallysafeintestinalDecoctioninthetreatmentofdiarrheatypeofirritablebowelsyndrome(IBS—D)liverdepressionandspleendeficiencyandintestinallossofsolidoxygentypeth5、eclinicalefficacyandsafety.Methods:Selectionconsistentwithclinicalinclusioncriteriaandexclusioncriteriaofliverdepressionandspleendeficiencyandintestinallossofsolidoxygentypeofdiarrheatypeofirritablebowelsyndromein96cases,usingarandomizedcontrolledprinciple,96patientswererandomlydividedintothetre6、atmentgroup48examples,thecontrolgroupof48cases.Thetreatmentgroupreceivedoralsolidintrinsicallysafeintestinalsoupdecoction,dailydoses,150mleachtime,beforebreakfastanddinnerafterheatingclothes;thecontrolgroupreceivedoralmaleicacidQumeiclothineachlOOmg,Lactobacilluscomplexcapsuleseachtime0.669,are37、timesaday,halfanhourbeforeoral.Thetwogroupswere4weeksaslcoursesoftreatment,observationoftreatment2,aftertheendoftreatmentforallcaseswereobservedtobestatisticalanalysiS,forefficacyandsafetyevaluationofeffectandeffectandmoreca
4、;临床研究SoIidintrinsicaIYsafeintestinaIDecoctioninthetreatmentofdiarrheatypeofiritabIeboweIsyndromeAbstractObjective:ToobservetheSolidintrinsicallysafeintestinalDecoctioninthetreatmentofdiarrheatypeofirritablebowelsyndrome(IBS—D)liverdepressionandspleendeficiencyandintestinallossofsolidoxygentypeth
5、eclinicalefficacyandsafety.Methods:Selectionconsistentwithclinicalinclusioncriteriaandexclusioncriteriaofliverdepressionandspleendeficiencyandintestinallossofsolidoxygentypeofdiarrheatypeofirritablebowelsyndromein96cases,usingarandomizedcontrolledprinciple,96patientswererandomlydividedintothetre
6、atmentgroup48examples,thecontrolgroupof48cases.Thetreatmentgroupreceivedoralsolidintrinsicallysafeintestinalsoupdecoction,dailydoses,150mleachtime,beforebreakfastanddinnerafterheatingclothes;thecontrolgroupreceivedoralmaleicacidQumeiclothineachlOOmg,Lactobacilluscomplexcapsuleseachtime0.669,are3
7、timesaday,halfanhourbeforeoral.Thetwogroupswere4weeksaslcoursesoftreatment,observationoftreatment2,aftertheendoftreatmentforallcaseswereobservedtobestatisticalanalysiS,forefficacyandsafetyevaluationofeffectandeffectandmoreca
此文档下载收益归作者所有